AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2016
Feb 1, 2016
31982_dirs_2016-02-01_5c9a0629-ffe7-43a6-877e-fbc2418e96a0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2016-01-31
Reporting Person: Trizzino John (SVP, Commercial Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-01-31 | Common Stock | P | 5855 | $3.63 | Acquired | 39564 | Direct |
Footnotes
F1: Includes 5,855 shares acquired under the Issuer's 2013 Employee Stock Purchase Plan on January 31, 2016.
More from NOVAVAX INC
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Annual Report
2026
Apr 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 26
Director's Dealing
2026
Jan 26